Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curevac N.V. (NQ: CVAC )

2.770 +0.110 (+4.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Curevac N.V.

< Previous 1 2 3 4 5 6 7 Next >
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
CureVac layoffs are coming for 30% of the vaccine company's employees as it prepares for a restructuring that will save it over 30% in costs. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
GOEV Stock: Canoo Receives Fleet Order From Go2 Delivery
Canoo stock is down on Wednesday as GOEV investors appear unimpressed by the company's new delivery van fleet deal with Go2 Delivery. 
Via InvestorPlace
DM Stock Alert: Nano Dimension Is Scooping Up Desktop Metal for $183 Million
Desktop Metal stock is up on Wednesday as DM investors learn of an acquisition deal with Nano Dimension for the company's shares. 
Via InvestorPlace
CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
CureVac stock is up on Wednesday as CVAC investors react to the company signing a new 1.4 billion euro licensing agreement with GSK. 
Via InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
GSK and CureVac restructured their collaboration into a new licensing agreement, prioritizing mRNA vaccine development. GSK gains full control of vaccine candidates for influenza and COVID-19, while... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For November 12, 2024
Via Benzinga
Insights into CureVac's Upcoming Earnings
Via Benzinga
GSK Reveals 'Positive' Data From Mid-Stage Study Of Seasonal Influenza mRNA Vaccine
GSK announced positive phase 2 trial results for its mRNA seasonal flu vaccine, showing strong immune. 
Via Benzinga
CVAC Stock Earnings: CureVac Misses EPS, Beats Revenue for Q2 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q1 2024
CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Southwest Airlines Adopts a Poison Pill Plan: 7 Things to Know
Southwest Airlines is in the news Wednesday after the airline company adopted a poison pill to battle activist investor Elliott Management. 
Via InvestorPlace
Why Is DouYu (DOYU) Stock Up 44% Today?
DouYu stock is up on Wednesday after the company announced a special cash dividend for DOYU investors payable in August. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out on Wednesday with our breakdown of all the biggest news affecting shares this morning. 
Via InvestorPlace
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month. 
Via Benzinga
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
Via Benzinga
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q4 2023
CVAC stock results show that CureVac missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
3 Stocks to Purge ASAP Before They’re Pulled off Life Support
Here are three stocks to sell now from your portfolio before they run out of cash and collapse. Avoid throwing good money after bad. 
Via InvestorPlace
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists. 
Via Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent... 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
Via Benzinga
CureVac, GS Partner Release Data On Influenza Vaccine Study
CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A... 
Via Benzinga
Why Biopharmaceutical Player CureVac Shares Are Rising Today
CureVac N.V. (NASDAQ: CVAC) shares are trading higher on Friday. 
Via Benzinga
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... 
Via Benzinga
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) related to seeking fair compensation for infringement of a portfolio of 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS